Wednesday, July 22, 2026

AWS Introduces DeepSeek-R1 Model to Enhance AI Solutions on Bedrock and SageMaker Platforms

AWS introduces the DeepSeek-R1 model via Amazon Bedrock and SageMaker, enhancing AI integration and security for users.

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube brand will sponsor Coachella, showcasing beauty tech and products to enhance global brand awareness.

Tag: MDD

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us